BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29183487)

  • 1. Bichat guidelines for the clinical management of botulism and bioterrorism-related botulism.
    Bossi P; Tegnell A; Baka A; Werner A; van Loock F; Hendriks J; Maidhof H; Gouvras G
    Euro Surveill; 2004 Dec; 9(12):31-32. PubMed ID: 29183487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bichat guidelines for the clinical management of botulism and bioterrorism-related botulism.
    Bossi P; Tegnell A; Baka A; van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
    Euro Surveill; 2004 Dec; 9(12):E13-4. PubMed ID: 15677843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulism.
    Sobel J
    Clin Infect Dis; 2005 Oct; 41(8):1167-73. PubMed ID: 16163636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intoxication of botulinum toxin].
    Chudzicka A
    Pol Merkur Lekarski; 2015 Sep; 39(231):153-6. PubMed ID: 26449577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin.
    Horowitz BZ
    Crit Care Clin; 2005 Oct; 21(4):825-39, viii. PubMed ID: 16168317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of botulism.
    Robinson RF; Nahata MC
    Ann Pharmacother; 2003 Jan; 37(1):127-31. PubMed ID: 12503947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulism: the challenge of diagnosis and treatment.
    Brook I
    Rev Neurol Dis; 2006; 3(4):182-9. PubMed ID: 17224901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Practice of botulism].
    Ikeguchi K
    Brain Nerve; 2011 Jul; 63(7):763-73. PubMed ID: 21747147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.
    Dembek ZF; Smith LA; Rusnak JM
    Disaster Med Public Health Prep; 2007 Nov; 1(2):122-34. PubMed ID: 18388640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin as a biological weapon: medical and public health management.
    Arnon SS; Schechter R; Inglesby TV; Henderson DA; Bartlett JG; Ascher MS; Eitzen E; Fine AD; Hauer J; Layton M; Lillibridge S; Osterholm MT; O'Toole T; Parker G; Perl TM; Russell PK; Swerdlow DL; Tonat K;
    JAMA; 2001 Feb; 285(8):1059-70. PubMed ID: 11209178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.
    Rao AK; Sobel J; Chatham-Stephens K; Luquez C
    MMWR Recomm Rep; 2021 May; 70(2):1-30. PubMed ID: 33956777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulism toxin, bioterrorist weapon].
    Bossi P; Bricaire F
    Presse Med; 2003 Mar; 32(10):463-5. PubMed ID: 12733311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulism disease].
    Marcus N; Hourvitz A
    Harefuah; 2002 May; 141 Spec No():73-7, 120. PubMed ID: 12170559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulin toxin: a weapon in terrorism.
    Josko D
    Clin Lab Sci; 2004; 17(1):30-4. PubMed ID: 15011978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulism.
    Davis LE
    Curr Treat Options Neurol; 2003 Jan; 5(1):23-31. PubMed ID: 12521561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulism and bioterrorism: how serious is this problem?
    Patocka J; Splino M; Merka V
    Acta Medica (Hradec Kralove); 2005; 48(1):23-8. PubMed ID: 16080379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.
    Anderson DM; Kumar VR; Arper DL; Kruger E; Bilir SP; Richardson JS
    PLoS One; 2019; 14(11):e0224700. PubMed ID: 31697731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foodborne botulism treated with heptavalent botulism antitoxin.
    Hill SE; Iqbal R; Cadiz CL; Le J
    Ann Pharmacother; 2013 Feb; 47(2):e12. PubMed ID: 23362041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt.
    Hibbs RG; Weber JT; Corwin A; Allos BM; Abd el Rehim MS; Sharkawy SE; Sarn JE; McKee KT
    Clin Infect Dis; 1996 Aug; 23(2):337-40. PubMed ID: 8842274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs.
    Barker D; Gillum KT; Niemuth NA; Kodihalli S
    PLoS One; 2019; 14(9):e0222670. PubMed ID: 31527885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.